John B Wong

Author PubWeight™ 141.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007 14.84
2 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2013 10.92
3 Effect of Vitamin D on falls: a meta-analysis. JAMA 2004 6.64
4 Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005 5.95
5 Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009 5.63
6 Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 2003 5.40
7 Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med 2007 4.54
8 Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003 4.44
9 Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med 2015 3.75
10 Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007 3.14
11 Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA 2008 3.01
12 Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. Value Health 2012 2.86
13 Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005 2.38
14 Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation 2012 2.24
15 Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making 2012 2.21
16 A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003 2.10
17 A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med 2014 1.93
18 ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation 2012 1.82
19 Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl 2004 1.69
20 ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. J Am Coll Cardiol 2011 1.69
21 Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 2005 1.66
22 Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med 2015 1.61
23 Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl 2002 1.57
24 Comparing the public health burden of chronic hepatitis C and HIV infection in France. J Hepatol 2004 1.57
25 Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. Ann Emerg Med 2004 1.48
26 A meta-analytic comparison of echocardiographic stressors. Int J Cardiovasc Imaging 2005 1.46
27 ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation 2011 1.32
28 Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes 2010 1.28
29 Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis. Ann Rheum Dis 2012 1.25
30 Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration. Clin Gastroenterol Hepatol 2013 1.19
31 Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms. Am J Kidney Dis 2008 1.17
32 Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J Bone Miner Res 2011 1.11
33 Health policy and cost-effectiveness analysis: yes we can. Yes we must. Ann Intern Med 2009 1.11
34 ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee. J Am Coll Cardiol 2012 1.11
35 ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. J Am Coll Cardiol 2012 1.06
36 Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990. Med Decis Making 2004 1.05
37 Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial. BMC Complement Altern Med 2014 1.04
38 Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy. Am J Gastroenterol 2007 1.03
39 Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics 2012 1.02
40 Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 2004 0.98
41 How (should) physicians think?: a journey from behavioral economics to the bedside. JAMA 2010 0.97
42 A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction. Am J Cardiol 2007 0.97
43 Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case. J Rheumatol 2003 0.96
44 Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J 2011 0.95
45 Interstate variation in the burden of fragility fractures. J Bone Miner Res 2009 0.95
46 Putting families in the center: family perspectives on decision making and ADHD and implications for ADHD care. J Atten Disord 2011 0.94
47 A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial. Clin Trials 2009 0.94
48 Simulation of hepatitis C based on a mandatory reporting system. Eur J Gastroenterol Hepatol 2002 0.93
49 A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther 2008 0.93
50 Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy. Radiology 2002 0.91
51 Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004 0.91
52 Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians. Pediatrics 2012 0.90
53 Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines. Pharmacoeconomics 2009 0.89
54 Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis. Ann Intern Med 2015 0.89
55 Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell. Bioconjug Chem 2009 0.87
56 Interferon for hepatitis C virus in hemodialysis--an individual patient meta-analysis of factors associated with sustained virological response. Clin J Am Soc Nephrol 2009 0.85
57 The economics of hepatitis C virus. Clin Liver Dis 2006 0.85
58 Receptor-targeted nanocomplexes optimized for gene transfer to primary vascular cells and explant cultures of rabbit aorta. Mol Ther 2008 0.84
59 ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol 2014 0.84
60 Propensity scores in the presence of effect modification: A case study using the comparison of mortality on hemodialysis versus peritoneal dialysis. Emerg Themes Epidemiol 2010 0.83
61 Economics of chronic hepatitis B and hepatitis C. J Hepatol 2007 0.83
62 Comparative Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis: A Randomized Trial. Ann Intern Med 2016 0.83
63 The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. Pharmacoeconomics 2005 0.82
64 Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis. Clin J Am Soc Nephrol 2011 0.82
65 Temporal lobe epilepsy surgery: what do patients want to know? Epilepsy Behav 2011 0.81
66 Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo. J Liposome Res 2006 0.81
67 Biophysical characterization of an integrin-targeted lipopolyplex gene delivery vector. Biochemistry 2007 0.80
68 Asymmetric synthesis of dialkyloxy-3-alkylammonium cationic lipids. J Org Chem 2004 0.80
69 ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Card Fail 2013 0.79
70 The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells. FEBS J 2009 0.79
71 Numeracy and framing bias in epilepsy. Epilepsy Behav 2010 0.78
72 Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians. Clin Infect Dis 2002 0.78
73 Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. Eur J Health Econ 2005 0.78
74 Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants. J Child Adolesc Psychopharmacol 2012 0.78
75 Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant 2011 0.78
76 Entering the new era of therapy for HBV and HCV infections. J Fam Pract 2010 0.77
77 Mono- and dicationic short PEG and methylene dioxyalkylglycerols for use in synthetic gene delivery systems. Org Biomol Chem 2008 0.77
78 Seizure frequency and patient-centered outcome assessment in epilepsy. Epilepsia 2014 0.77
79 All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms. J Gen Intern Med 2004 0.76
80 Presidential reflections on the 25th anniversary of the society for medical decision making. Med Decis Making 2004 0.76
81 ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons. Catheter Cardiovasc Interv 2012 0.76
82 ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 2012 0.75
83 Evidence-based medicine, pharmacogenetics, and antiplatelet therapy decision making for acute coronary syndrome. Ann Intern Med 2014 0.75
84 "We make the path by walking it": building an academic community partnership with Boston Chinatown. Prog Community Health Partnersh 2014 0.75
85 Recent national trends in acute myocardial infarction hospitalizations in Medicare: shrinking declines and growing disparities. Epidemiology 2015 0.75
86 ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos. Value Health 2013 0.75
87 Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response. Med Care 2017 0.75
88 DEALE-ing with lung cancer and heart failure. Med Decis Making 2005 0.75
89 PROPENSITY SCORE-BASED METHODS IN COMPARATIVE EFFECTIVENESS RESEARCH ON CORONARY ARTERY DISEASE. Am J Epidemiol 2017 0.75
90 ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Soc Echocardiogr 2017 0.75
91 Comparative effectiveness research and the psychology of medical practice: the vicissitudes of knowledge implementation. Pharmacoeconomics 2010 0.75